AI assistant
Sending…
Adicet Bio, Inc. — Director's Dealing 2020
Sep 18, 2020
34412_dirs_2020-09-17_1b9880a2-993c-41a4-acdf-137192cde881.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-09-17
Reporting Person: Schor Chen (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-17 | Stock Option (Right to Buy) | $16.11 | A | 872111 | Acquired | 2030-09-16 | Common Stock (872111) | Direct |
Footnotes
F1: 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries.
More from Adicet Bio, Inc.
Annual Report
2026
May 20
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27